The Public Register provides free annual reports of public companies trading on the NYSE, NASDAQ, AMEX, OTC and TSX exchanges. We aim to provide a quality service that fulfills annual report orders in a timely manner. Orders are processed and mailed within one business day.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.
Our portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com) , follow Gilead on Twitter (@GileadSciences).